Advent France Biotechnology
General contacts
Investor type
VC
Founded
2015
AUM
$65 M
Location
France
Investor profile last updated: 31 October, 2021
Profile
Advent France Biotechnology focuses on ground-breaking innovations in Life Sciences to address unmet medical and clinical needs, building the next generation of pioneering healthcare companies. Keeping in mind patients’ well-being, we believe in improving medical care and taking medical innovations further ahead. We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and drive inventive Life Sciences start-ups to success.
Industry
Contacts
Name
Title
Email
Social Networks
Investment-team contacts for Advent France Biotechnology — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
FAQs about Advent France Biotechnology
Is Advent France Biotechnology a venture capital or private equity firm?
Advent France Biotechnology is a venture capital firm. It backs companies at Seed and Series A, writing tickets of $1-5 m.
Where is Advent France Biotechnology located?
Advent France Biotechnology is located in France.
When was Advent France Biotechnology founded?
Advent France Biotechnology was founded in 2015.
What sectors and industries does Advent France Biotechnology invest in?
Advent France Biotechnology invests in companies and startups in Agriculture, Biotechnology, Food and Beverage, Foodtech, Healthcare Services, Medical Devices, MedTech, Life Sciences, HealthTech, AgriTech.
What is Advent France Biotechnology geographical focus of investments?
Advent France Biotechnology invests in companies and startups in Europe.
At what stages of companies and startups does Advent France Biotechnology typically invest in?
Advent France Biotechnology invests in companies and startups at Seed, Series A.
What is the usual amount of Advent France Biotechnology investment?
Advent France Biotechnology usually invests $1-5 m on average.
What is the amount of assets of under management (AUM) for Advent France Biotechnology?
Advent France Biotechnology has around $65m assets under management.
What are the contacts of Advent France Biotechnology?
Advent France Biotechnology can be reached through its website adventfb.com/en, its LinkedIn page and its X account. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Advent France Biotechnology — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Can I access Advent France Biotechnology data via API or MCP?
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Advent France Biotechnology directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
When was the Advent France Biotechnology profile last updated?
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 31 October, 2021. Something out of date here? Report it — we re-run that firm within 48h and get back to you.